Table 1 Pathways affected by the putative targets of miR-625
From: MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines
KEGG Pathway | Gene Name | Found Genes | -ln(p-value) | KEGG Pathway ID |
|---|---|---|---|---|
Ubiquitin mediated proteolysis | UBE2NL, UBE2N, FBXW7, SIAH1 | 4 | 12.75 | hsa04120 |
p53 signaling pathway | SIAH1, IGF1 | 2 | 4.77 | hsa04115 |
Regulation of autophagy | ATG5 | 1 | 1.62 | hsa04140 |
Focal adhesion | COL1A1, IGF1 | 2 | 1.27 | hsa04510 |
Neurodegenerative Diseases | FBXW7 | 1 | 1.16 | hsa01510 |
Lysine degradation | SETD1A | 1 | 1.16 | hsa00310 |
mTOR signaling pathway | IGF1 | 1 | 0.9 | hsa04150 |
Glioma | IGF1 | 1 | 0.59 | hsa05214 |
Glycerophospholipid metabolism | ACHE | 1 | 0.55 | hsa00564 |
Renal cell carcinoma | ARNT | 1 | 0.52 | hsa05211 |
Melanoma | IGF1 | 1 | 0.49 | hsa05218 |
Long-term depression | IGF1 | 1 | 0.46 | hsa04730 |
ECM-receptor interaction | COL1A1 | 1 | 0.4 | hsa04512 |
Hematopoietic cell lineage | CSF3R | 1 | 0.39 | hsa04640 |
Neuroactive ligand-receptor interaction | GHRHR | 1 | 0.37 | hsa04080 |
Cytokine-cytokine receptor interaction | CSF3R | 1 | 0.37 | hsa04060 |
Prostate cancer | IGF1 | 1 | 0.32 | hsa05215 |
TGF-beta signaling pathway | FST | 1 | 0.31 | hsa04350 |
Axon guidance | SEMA6C | 1 | 0.1 | hsa04360 |
Cell Communication | COL1A1 | 1 | 0.04 | hsa01430 |
Jak-STAT signaling pathway | CSF3R | 1 | 0.01 | hsa04630 |
Wnt signaling pathway | SIAH1 | 1 | 0 | hsa04310 |